I'm kind of talking about two groups of drugs. One is the generic experience for simple molecules in the last 10 years. We've had the pan-Canadian pharmaceutical alliance controlling prices, pushing them down and decreasing the number of manufacturers. We've also had these drug catastrophes coming along, and manufacturer contaminants.
That's one area. The price is so low on them that manufacturers are dropping out and we're having trouble supplying.